Medical Second Opinion Service is the additional consultation taken by the patient after the primary diagnosis. The patient can opt for a medical second opinion if the patient feels dissatisfied with the diagnosis or if there is a need for further validation in case of some serious surgical procedures. There has been an upward surge in medical second opinion services mainly due to financial, health and legal costs involved in the treatment. The increased need for improved diagnosis and treatment planning, reducing the financial cost, and ease of interaction is expected to propel the market growth in the forecast period.
United States is the largest consumption place, with a consumption market share nearly 41% in 2017. Following United States, Europe is the second largest consumption place with the consumption market share of 28%.

According to this study, over the next five years the Medical Second Opinion market will register a 21.0% CAGR in terms of revenue, the global market size will reach US$ 7010 million by 2024, from US$ 2700 million in 2019. In particular, this report presents the global revenue market share of key companies in Medical Second Opinion business, shared in Chapter 3.

This report presents a comprehensive overview, market shares and growth opportunities of Medical Second Opinion market by product type, application, key companies and key regions.

This study considers the Medical Second Opinion value generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019 in Section 2.3; and forecast to 2024 in section 10.7.
Hospitals
Medical Second Opinion Providing Companies
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 10.8.
Cancer
Diabetes
Cardiac Disorders
Neurological Disorders
Ocular Disorders
Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
HCA Hospitals
AXA PPP Healthcare
Royal London Group
Helsana Group
Cleveland Clinic
Amradnet
Best Doctors Inc
Inova Care
Toranomon Hospital
Keio University Hospital
Johns Hopkins Medicine
Penn Medicine
Oncology International Pvt. Ltd.
GrandOpinion
London Pain Clinic
Mondial Assistance
Medisense
Medo Asia Sdn. Bhd.

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Medical Second Opinion market size by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Medical Second Opinion market by identifying its various subsegments.
Focuses on the key global Medical Second Opinion players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Medical Second Opinion with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the size of Medical Second Opinion submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.